Indian Ministry of Health

organization

Last mentioned: Mar 24, 2026

Timeline

  1. Prescription Crackdown

    Expected implementation of stricter digital prescription tracking for GLP-1 medications.

  2. Regulatory Warning

    India's CDSCO issues a formal alert regarding the misuse of affordable weight-loss jabs.

  3. Generic Entry

    Indian pharmaceutical firms begin ramping up production of low-cost semaglutide biosimilars.

  4. Global Shortages

    High demand for GLP-1 drugs in Western markets leads to global supply constraints.

Stories mentioning Indian Ministry of Health 1

regulation Bearish

India Issues Regulatory Alert Over Misuse of Low-Cost GLP-1 Weight-Loss Jabs

Indian health authorities have issued a formal warning regarding the rising misuse of affordable weight-loss injections, highlighting risks associated with unsupervised administration. As the domestic market for GLP-1 receptor agonists expands, regulators are moving to curb off-label cosmetic use that threatens public health and drug availability for diabetic patients.

2 sources